Sailaja Puttagunta Iterum Therapeutics PLC (ITRM) insider trading activity

Sailaja Puttagunta is Chief Medical Officer of Iterum Therapeutics plc. Currently has a direct ownership of 10,369 shares of ITRM, which is worth approximately $21,878. The most recent transaction as insider was on Dec 01, 2023, when has been sold 2,933 shares (Ordinary Shares) at a price of $2.12 per share, resulting in proceeds of $6,217. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.4K

0% 3M change

108.67% 12M change

Total Value Held $21,878

Sailaja Puttagunta Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2023	SELL Payment of exercise price or tax liability	$6,217 $2.12 p/Share	2,933 Reduced 22.05%	10,369 Ordinary Shares
Dec 01 2023	BUY Grant, award, or other acquisition	-	8,333 Added 38.52%	13,302 Ordinary Shares
Dec 02 2022	SELL Open market or private sale	$4,441 $1.32 p/Share	3,365 Reduced 40.38%	4,969 Ordinary Shares
Dec 01 2022	BUY Grant, award, or other acquisition	-	8,334 Added 50.0%	8,334 Ordinary Shares

Also insider at

PHGE

BiomX Inc. Healthcare

Chief Medical Officer